Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td

Clinical trial NCT00601835 · COMPLETED

Trial details

NCT number: NCT00601835
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diphtheria Tetanus

Start date: 2004-05-01
Primary completion: 2005-07-01
Enrollment: 3651

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.